Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies.
Identifieur interne : 001D98 ( PubMed/Curation ); précédent : 001D97; suivant : 001D99Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies.
Auteurs : Phillip J. Tully [France] ; Olivier Hanon ; Suzanne Cosh ; Christophe TzourioSource :
- Journal of hypertension [ 1473-5598 ] ; 2016.
Descripteurs français
- KwdFr :
- Antihypertenseurs (usage thérapeutique), Association de médicaments, Diurétiques (usage thérapeutique), Diurétiques d'épargne potassique (usage thérapeutique), Démence (épidémiologie), Facteurs de protection, Humains, Hypertension artérielle (traitement médicamenteux), Inhibiteurs du symport chlorure potassium sodium (usage thérapeutique), Maladie d'Alzheimer (épidémiologie), Études prospectives.
- MESH :
- traitement médicamenteux : Hypertension artérielle.
- usage thérapeutique : Antihypertenseurs, Diurétiques, Diurétiques d'épargne potassique, Inhibiteurs du symport chlorure potassium sodium.
- épidémiologie : Démence, Maladie d'Alzheimer.
- Association de médicaments, Facteurs de protection, Humains, Études prospectives.
English descriptors
- KwdEn :
- Alzheimer Disease (epidemiology), Antihypertensive Agents (therapeutic use), Dementia (epidemiology), Diuretics (therapeutic use), Diuretics, Potassium Sparing (therapeutic use), Drug Therapy, Combination, Humans, Hypertension (drug therapy), Prospective Studies, Protective Factors, Sodium Potassium Chloride Symporter Inhibitors (therapeutic use).
- MESH :
- chemical , therapeutic use : Antihypertensive Agents, Diuretics, Diuretics, Potassium Sparing, Sodium Potassium Chloride Symporter Inhibitors.
- drug therapy : Hypertension.
- epidemiology : Alzheimer Disease, Dementia.
- Drug Therapy, Combination, Humans, Prospective Studies, Protective Factors.
Abstract
Diuretic drugs have been a mainstay of hypertension treatment in the elderly however their dementia sparing effects are under-reported. The objective was to quantify dementia risk in relation to diuretic antihypertensive drugs.
DOI: 10.1097/HJH.0000000000000868
PubMed: 26886565
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001E22
Links to Exploration step
pubmed:26886565Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies.</title><author><name sortKey="Tully, Phillip J" sort="Tully, Phillip J" uniqKey="Tully P" first="Phillip J" last="Tully">Phillip J. Tully</name><affiliation wicri:level="1"><nlm:affiliation>aUniversity Bordeaux, Neuroepidemiology, UMR, Bordeaux, France bFreemasons Foundation Centre for Men's Health, Discipline of Medicine, School of Medicine, The University of Adelaide, Adelaide, Australia cINSERM, Service de Gériatrie, Université Paris Descartes, Hôspital Broca, Paris, France dSchool of Psychology, The University of Adelaide, Adelaide, Australia eINSERM, Neuroepidemiology, UMR, Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>aUniversity Bordeaux, Neuroepidemiology, UMR, Bordeaux, France bFreemasons Foundation Centre for Men's Health, Discipline of Medicine, School of Medicine, The University of Adelaide, Adelaide, Australia cINSERM, Service de Gériatrie, Université Paris Descartes, Hôspital Broca, Paris, France dSchool of Psychology, The University of Adelaide, Adelaide, Australia eINSERM, Neuroepidemiology, UMR, Bordeaux</wicri:regionArea></affiliation></author><author><name sortKey="Hanon, Olivier" sort="Hanon, Olivier" uniqKey="Hanon O" first="Olivier" last="Hanon">Olivier Hanon</name></author><author><name sortKey="Cosh, Suzanne" sort="Cosh, Suzanne" uniqKey="Cosh S" first="Suzanne" last="Cosh">Suzanne Cosh</name></author><author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26886565</idno><idno type="pmid">26886565</idno><idno type="doi">10.1097/HJH.0000000000000868</idno><idno type="wicri:Area/PubMed/Corpus">001E22</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E22</idno><idno type="wicri:Area/PubMed/Curation">001D98</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001D98</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies.</title><author><name sortKey="Tully, Phillip J" sort="Tully, Phillip J" uniqKey="Tully P" first="Phillip J" last="Tully">Phillip J. Tully</name><affiliation wicri:level="1"><nlm:affiliation>aUniversity Bordeaux, Neuroepidemiology, UMR, Bordeaux, France bFreemasons Foundation Centre for Men's Health, Discipline of Medicine, School of Medicine, The University of Adelaide, Adelaide, Australia cINSERM, Service de Gériatrie, Université Paris Descartes, Hôspital Broca, Paris, France dSchool of Psychology, The University of Adelaide, Adelaide, Australia eINSERM, Neuroepidemiology, UMR, Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>aUniversity Bordeaux, Neuroepidemiology, UMR, Bordeaux, France bFreemasons Foundation Centre for Men's Health, Discipline of Medicine, School of Medicine, The University of Adelaide, Adelaide, Australia cINSERM, Service de Gériatrie, Université Paris Descartes, Hôspital Broca, Paris, France dSchool of Psychology, The University of Adelaide, Adelaide, Australia eINSERM, Neuroepidemiology, UMR, Bordeaux</wicri:regionArea></affiliation></author><author><name sortKey="Hanon, Olivier" sort="Hanon, Olivier" uniqKey="Hanon O" first="Olivier" last="Hanon">Olivier Hanon</name></author><author><name sortKey="Cosh, Suzanne" sort="Cosh, Suzanne" uniqKey="Cosh S" first="Suzanne" last="Cosh">Suzanne Cosh</name></author><author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name></author></analytic><series><title level="j">Journal of hypertension</title><idno type="eISSN">1473-5598</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer Disease (epidemiology)</term><term>Antihypertensive Agents (therapeutic use)</term><term>Dementia (epidemiology)</term><term>Diuretics (therapeutic use)</term><term>Diuretics, Potassium Sparing (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Hypertension (drug therapy)</term><term>Prospective Studies</term><term>Protective Factors</term><term>Sodium Potassium Chloride Symporter Inhibitors (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antihypertenseurs (usage thérapeutique)</term><term>Association de médicaments</term><term>Diurétiques (usage thérapeutique)</term><term>Diurétiques d'épargne potassique (usage thérapeutique)</term><term>Démence (épidémiologie)</term><term>Facteurs de protection</term><term>Humains</term><term>Hypertension artérielle (traitement médicamenteux)</term><term>Inhibiteurs du symport chlorure potassium sodium (usage thérapeutique)</term><term>Maladie d'Alzheimer (épidémiologie)</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antihypertensive Agents</term><term>Diuretics</term><term>Diuretics, Potassium Sparing</term><term>Sodium Potassium Chloride Symporter Inhibitors</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hypertension</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Alzheimer Disease</term><term>Dementia</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Hypertension artérielle</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antihypertenseurs</term><term>Diurétiques</term><term>Diurétiques d'épargne potassique</term><term>Inhibiteurs du symport chlorure potassium sodium</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Démence</term><term>Maladie d'Alzheimer</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term><term>Humans</term><term>Prospective Studies</term><term>Protective Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term><term>Facteurs de protection</term><term>Humains</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Diuretic drugs have been a mainstay of hypertension treatment in the elderly however their dementia sparing effects are under-reported. The objective was to quantify dementia risk in relation to diuretic antihypertensive drugs.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26886565</PMID><DateCreated><Year>2016</Year><Month>04</Month><Day>28</Day></DateCreated><DateCompleted><Year>2017</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2017</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-5598</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of hypertension</Title><ISOAbbreviation>J. Hypertens.</ISOAbbreviation></Journal><ArticleTitle>Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies.</ArticleTitle><Pagination><MedlinePgn>1027-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/HJH.0000000000000868</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Diuretic drugs have been a mainstay of hypertension treatment in the elderly however their dementia sparing effects are under-reported. The objective was to quantify dementia risk in relation to diuretic antihypertensive drugs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic databases were searched until June 2015.</AbstractText><AbstractText Label="ELIGIBILITY CRITERIA" NlmCategory="METHODS">population, adults without dementia from primary care, community cohort, residential/institutionalized, or randomized controlled trial; exposure, diuretic antihypertensive drug; comparison, no diuretic drug, other or no antihypertensive drug, placebo-control; outcome, incident dementia diagnosed by standardized criteria. Adjusted hazard ratios (HR) with 95% confidence intervals (CI) were pooled in fixed-effects models with RevMan 5.3 (The Nordic Cochrane Centre, Copenhagen, Denmark) and the findings rated according to The Grading of Recommendations Assessment, Development and Evaluation criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 15 articles were included (52 599 persons, 3444 dementia cases, median age 76.1 years) and median follow-up was 6.1 years. Diuretics were associated with reduced dementia risk (HR 0.83; 95% CI 0.76-0.91, P < 0.0001, I = 0) and Alzheimer's disease risk (HR 0.82; 95% CI 0.71-0.94, P = 0.004, I = 0). Stratified analysis indicated a difference between potassium sparing, thiazide and loop diuretics (P = 0.01). Risk estimates were generally consistent comparing monotherapy vs. combination therapy, study design and follow-up. Meta-regression showed that demographics, stroke, heart failure, diabetes, liver disease, attrition, mortality rate, cognitive function, and apolipoprotein E allele did not moderate the results.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Diuretic antihypertensive drugs were associated with a consistent reduction in dementia risk without heterogeneity, pointing to generalizability of these findings.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="BACKGROUND">PROSPERO [CRD42015023428].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tully</LastName><ForeName>Phillip J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>aUniversity Bordeaux, Neuroepidemiology, UMR, Bordeaux, France bFreemasons Foundation Centre for Men's Health, Discipline of Medicine, School of Medicine, The University of Adelaide, Adelaide, Australia cINSERM, Service de Gériatrie, Université Paris Descartes, Hôspital Broca, Paris, France dSchool of Psychology, The University of Adelaide, Adelaide, Australia eINSERM, Neuroepidemiology, UMR, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanon</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Cosh</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tzourio</LastName><ForeName>Christophe</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Hypertens</MedlineTA><NlmUniqueID>8306882</NlmUniqueID><ISSNLinking>0263-6352</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004232">Diuretics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062865">Diuretics, Potassium Sparing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D049994">Sodium Potassium Chloride Symporter Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004232" MajorTopicYN="N">Diuretics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062865" MajorTopicYN="N">Diuretics, Potassium Sparing</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065840" MajorTopicYN="N">Protective Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049994" MajorTopicYN="N">Sodium Potassium Chloride Symporter Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26886565</ArticleId><ArticleId IdType="doi">10.1097/HJH.0000000000000868</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D98 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001D98 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:26886565
|texte= Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:26886565" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |